quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:15:00·300d
PRRelease
Channel Therapeutics Corporation logo

Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement

CHRO· Channel Therapeutics Corporation
Health Care
Original source

Companies

  • CHRO
    Channel Therapeutics Corporation
    Health Care

Related

  • SEC287d
    SEC Form D filed by Channel Therapeutics Corporation
  • PR287d
    Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum
  • SEC289d
    SEC Form SCHEDULE 13G filed by Channel Therapeutics Corporation
  • INSIDER290d
    SEC Form 4 filed by Director Baxter Richard B
  • INSIDER290d
    SEC Form 4 filed by Director Greenleaf Peter
  • INSIDER290d
    SEC Form 4 filed by Director Pauls Matthew
  • INSIDER290d
    SEC Form 4 filed by CFO, Treas & Secty Francis Knuettel Ii
  • INSIDER290d
    SEC Form 4 filed by Director Davis Todd C
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022